Kymera Therapeutics

Kymera is pioneering a transformative new approach to treating previously untreatable diseases — targeted protein degradation — accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins and advance new treatment options for patients.

Headquarters Cambridge, MA
Website kymeratx.com
Pipeline Preclinical
Twitter @kymeratx​
Partners GSK